Treating CD30-Expressing Cutaneous T-Cell Lymphoma
Introduction to CD30
Evaluation of CD30 Expression in Lymphomas
Pathology Report of CD30 Expression
Testing Methodology for CD30 Expression
CD30 Staining in pcALCL vs MF/SS
Issues Related to CD30-Negative Expression
CD30 Testing in Other Lymphoma Conditions
Therapeutic Approach for Patients With CD30-Positive MF/SS
Long-Term Management of Patients Receiving Systemic Therapies
ALCANZA Trial Study Design
ALCANZA Trial Efficacy
ALCANZA Trial Safety Profile
Treatment Strategy With BV
Factors to Consider in Optimizing Course of Treatment
MAVORIC Trial Study Design
MAVORIC Trial Patient Characteristics and Efficacy
ALCANZA vs MAVORIC
MAVORIC Trial Safety Profile
Potential Increase in GVHD in Patients With CTCL After Mogamulizumab Treatment
Ongoing Clinical Trials
Key Takeaways
Abbreviations
Abbreviations (cont)
Abbreviations (cont)